Digoxin, an Overlooked Agonist of RORγ/RORγT
Digoxin was one of the first identified RORγT receptor inverse agonists inhibiting the differentiation of Th17 cells. However, this compound exhibits inhibitory activity at relatively high concentrations that mediate cytotoxic effects. We previously identified several cardenolides that are structura...
Saved in:
Main Authors: | Kaja Karaś (Author), Anna Sałkowska (Author), Marta Sobalska-Kwapis (Author), Aurelia Walczak-Drzewiecka (Author), Dominik Strapagiel (Author), Jarosław Dastych (Author), Rafał A. Bachorz (Author), Marcin Ratajewski (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Natural compounds ursolic acid and digoxin exhibit inhibitory activities to cancer cells in RORγ-dependent and -independent manner
by: Hongye Zou, et al.
Published: (2023) -
Development of dual GPBAR1 agonist and RORγt inverse agonist for the treatment of inflammatory bowel diseases
by: Michele Biagioli, et al.
Published: (2024) -
Effects of RORγt overexpression on the murine central nervous system
by: Tetsuya Sasaki, et al.
Published: (2021) -
Small molecule inhibitors of RORγt for Th17 regulation in inflammatory and autoimmune diseases
by: Jiuping Zeng, et al.
Published: (2023) -
Targeting castration-resistant prostate cancer with a novel RORγ antagonist elaiophylin
by: Jianwei Zheng, et al.
Published: (2020)